Bank of New York Mellon Corp Sells 10,405 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Bank of New York Mellon Corp reduced its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 384,844 shares of the company’s stock after selling 10,405 shares during the quarter. Bank of New York Mellon Corp owned about 0.78% of Prestige Consumer Healthcare worth $30,052,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Kestra Investment Management LLC purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $27,000. Huntington National Bank boosted its holdings in Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after acquiring an additional 181 shares during the last quarter. Covestor Ltd boosted its holdings in Prestige Consumer Healthcare by 95.6% during the 3rd quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after acquiring an additional 654 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares in the last quarter. Finally, Blue Trust Inc. raised its holdings in shares of Prestige Consumer Healthcare by 24.8% in the fourth quarter. Blue Trust Inc. now owns 2,190 shares of the company’s stock valued at $158,000 after purchasing an additional 435 shares during the last quarter. Institutional investors own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

PBH has been the topic of a number of recent analyst reports. Oppenheimer lifted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target for the company. in a research note on Monday, December 9th. Finally, Canaccord Genuity Group upped their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $92.60.

Prestige Consumer Healthcare Stock Up 2.3 %

PBH stock opened at $89.10 on Friday. The company has a market capitalization of $4.41 billion, a price-to-earnings ratio of 20.87, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The business’s 50 day moving average price is $80.80 and its two-hundred day moving average price is $77.83. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $89.65.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.